Platelet-Derived Extracellular Vesicles for Hemostasis and Bleeding Reduction in TBI – Every Labs
Every Labs shared a post on LinkedIn about a recent article by Alpa Trivedi et al., pubished in Journal of Translational Medicine, adding:
“Freeze-dried platelet vesicles cut bleeding in the injured brain, no cold chain needed.
New in the Journal of Translational Medicine (July 20, 2026), a UCSF-led team tested freeze-dried platelet-derived extracellular vesicles (LPEVs) in traumatic brain injury. Mice received one dose 40 minutes after controlled cortical impact.
Why this matters
- Hemorrhage is the leading cause of preventable death worldwide; intracranial bleeding drives early deaths after TBI.
- TBI is the top cause of death and disability in people aged 1 to 44 globally.
- Freeze-dried vesicles need no cold chain, so they could ride in an ambulance or field kit.
Key takeaways
- One LPEV dose 40 minutes post-injury significantly reduced intracranial hemorrhage in a mouse cortical impact model.
- LPEVs generated thrombin and sped clot formation in blood from healthy donors, trauma patients, and dysfunctional platelets.
- Effects ran through GPIIb/IIIa-dependent platelet aggregation; blood-brain barrier permeability and neuroinflammation were unchanged.
Reality check
The authors note LPEVs kept platelets’ hemostatic cargo but lost vasculoprotective factors, decoupling bleeding control from barrier protection. Human trials and dosing studies come next.
Bottom line
A shelf-stable vesicle product may stop brain bleeding early after trauma, though barrier repair will need something more.
Institutions
- University of California, San Francisco
- Cellphire Therapeutics, Inc.
- Vitalant Research Institute
- Uniformed Services University
Citation
Lyophilized platelet derived extracellular vesicles promote hemostasis and attenuate intracranial hemorrhage following traumatic brain injury Trivedi et al., Journal of Translational Medicine (2026). Volume and article number not yet indexed at time of writing.”
Title: Lyophilized platelet derived extracellular vesicles promote hemostasis and attenuate intracranial hemorrhage following traumatic brain injury
Authors: Alpa Trivedi, Byron Miyazawa, Alexander T. Fields, Michael Matthews, Lindsay Vivona, Callie Keane, Daniel Potter, Huimin Geng, Haoqian Zhang, Hiroki Taenaka, Serena S. Kwek, Kimberly Herrera-Rodriguez, Brenda Nunez-Garcia, Erika Marques de Menezes, Mark Barry, Alison Nair, Ben Kuhn, Philip J. Norris, Lawrence Fong, Michael M. Fitzpatrick, Martin Schreiber, Lucy Z. Kornblith and Shibani Pati

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 10:01Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine